Search
HZT-501
go.drugbank.com/drugs/DB05369InvestigationalIt has entered Phase 3 clinical trials in March 2007 for reduction of the risk of development of ibuprofen-associated upper gastrointestinal (i.e., gastric and/or duodenal) ulcers.
SN-38
go.drugbank.com/drugs/DB05482InvestigationalSN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others.
Tozasertib
go.drugbank.com/drugs/DB19675InvestigationalTozasertib has a monoisotopic molecular weight of 464.21 Da.
Conteltinib
go.drugbank.com/drugs/DB21262InvestigationalConteltinib has a monoisotopic molecular weight of 635.34 Da.
Osunprotafib
go.drugbank.com/drugs/DB21547InvestigationalOsunprotafib has a monoisotopic molecular weight of 385.15 Da.
Zelicapavir
go.drugbank.com/drugs/DB21662InvestigationalZelicapavir has a monoisotopic molecular weight of 549.17 Da.
Zoracopan
go.drugbank.com/drugs/DB21702InvestigationalZoracopan has a monoisotopic molecular weight of 614.16 Da.
LU-31130
go.drugbank.com/drugs/DB05828ExperimentalIt acts at the Dopamine D4 receptors in the cortex and has low affinity for D2 receptors, adrenoceptors, muscarinic and histaminergic receptors.
MEM 1414
go.drugbank.com/drugs/DB05888ExperimentalThis drug candidate has completed Phase 1 clinical trials. MEM 1414 works by blocking phosphodiesterase, an enzyme that breaks down an important brain chemical, cyclic AMP.
EW-A-401
go.drugbank.com/drugs/DB05525InvestigationalThis specific transcription factor has been shown in animal studies to increase expression of the VEGF-A gene, and to promote the growth of new blood vessels.